Although tumor cells have directly present tumor antigens to MHC-I playing a strong part in the effector function of CD8+ T cells, it is necessary that primary CD8+ T cells need to be cross-presented by specialized antigen-presenting cells (especially DCs) to maintain the cytotoxic immune response. Here, CD8A is linked to neoplasm.